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Abstract: A large number of medically important viruses,
including HIV, hepatitis C virus, and influenza, have RNA
genomes. These viruses replicate with extremely high
mutation rates and exhibit significant genetic diversity.
This diversity allows a viral population to rapidly adapt to
dynamic environments and evolve resistance to vaccines
and antiviral drugs. For the last 30 years, quasispecies
theory has provided a population-based framework for
understanding RNA viral evolution. A quasispecies is a
cloud of diverse variants that are genetically linked
through mutation, interact cooperatively on a functional
level, and collectively contribute to the characteristics of
the population. Many predictions of quasispecies theory
run counter to traditional views of microbial behavior and
evolution and have profound implications for our
understanding of viral disease. Here, we discuss basic
principles of quasispecies theory and describe its rele-
vance for our understanding of viral fitness, virulence, and
antiviral therapeutic strategy.
Introduction
The rapid evolution of RNA viruses complicates the manage-
ment of chronic infections and the control of emerging infectious
agents [1–3]. The ongoing global AIDS pandemic and the
resurgence of influenza highlight the difficulties associated with
these genetically labile pathogens [4–6]. RNA viruses have also
been responsible for recent sporadic epidemics of emerging and
reemerging viral diseases including dengue, West Nile fever, and
Ebola [7,8]. Because of their high mutation rates, these viruses are
moving targets for therapeutic intervention and frequently develop
resistance to vaccines and antiviral drugs [9]. A clearer
understanding of viral evolutionary dynamics and its relationship
to virulence and drug resistance may facilitate the development of
more effective therapeutics.
The evolutionary dynamics of RNA viruses are complex and
their high mutation rates, rapid replication kinetics, and large
population sizes present a challenge to traditional population
genetics [10]. Quasispecies theory is a mathematical framework
that was initially formulated to explain the evolution of life in the
‘‘precellular RNA world [11].’’ It builds on classical population
genetics, but seeks to explore the consequences of error-prone
replication and near-infinite population sizes for genome evolution
[12,13]. More recently, quasispecies theory has been used to
describe the evolutionary dynamics of RNA viruses, and many of
its predictions have been validated experimentally in model
systems [2,14,15]. Some of these observations challenge more
traditional views of evolution and have profound implications for
the control and treatment of viral diseases.
Here we explain basic aspects of quasispecies theory, describe
key experiments that define ‘‘quasispecies effects,’’ and highlight
how these results may shape our view of viral pathogenesis,
antiviral drug development, and vaccine design. We will stress
three clinically relevant principles. First, the fitness of a particular
virus sequence may be determined more by its freedom to mutate
into related sequences than by its own replicative capacity.
Second, many viruses operate near a threshold of ‘‘error
catastrophe’’ and may be combated by increasing their replication
error rates. Third, increasing the fidelity of genome replication
may paradoxically attenuate viruses.
Error-Prone Replication and Viral Quasispecies
Most viruses encode enzymes responsible for replicating their
DNA or RNA genomes. The intrinsic error rate, or fidelity, of the
replicase determines the mutation rate for that virus and the
range of genetic variation upon which natural selection can act.
Viral RNA polymerases exhibit characteristically low fidelity with
measured mutation rates of roughly 10
24 mutations per
nucleotide copied, which is orders of magnitude greater than
those of nearly all DNA-based viruses and organisms [10,15,16].
Given the large population sizes observed in both experimental
and natural infections, it is estimated that every possible point
mutation and many double mutations are generated with each
viral replication cycle and may be present within the population
at any time [17]. Because RNA viruses exist as swarms of similar
variants that are continuously regenerated by mutation of related
sequences, our ability to predict the outcome of an infection or a
therapeutic intervention from studies of isolated clones is limited.
Even a defined molecular clone will quickly transform into a
collection of related sequences when introduced into cells. This
collection is the quasispecies and is organized around a master
sequence [12].
The genetic organization of populations is often depicted using
the concept of sequence space, a geometric representation of all
possible sequences where physical distance reflects genetic
similarity. For example, a given viral genome will undergo
replication and generate hundreds of progeny that differ at
roughly one position (Figure 1). Subsequent rounds of replication
will generate a more complex mutant distribution with variants
lying farther away from each other in sequence space. This
ensemble of mutants forms a ‘‘cloud’’ of variants, or quasispecies,
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pruned by natural selection. According to population genetics, the
frequency of a given variant in a population is closely
approximated by its ability to survive and reproduce—its fitness.
In quasispecies formulations, where mutation rates are elevated,
frequency is also subject to the probability that the variant will be
generated de novo by mutation of its neighbors in sequence space
[12]. In RNA viruses, the contribution of mutation to genotype
frequency is significant, and variants are ‘‘coupled’’ in sequence
space [18]. That is, a low fitness variant can be maintained at a
higher than expected frequency because it is coupled to a well-
represented, higher fitness genotype in sequence space. The
phenomenon of mutational coupling is one of the defining
characteristics of a quasispecies, as it places individual mutants
within a functional network of variants [2].
Viral populations evolve within a fitness landscape where the
‘‘ground level’’ is a representation of the range of genotypes in
sequence space. The ‘‘altitude’’ at any given location is the fitness
associated with that particular genotype. The environment and its
selective pressures determine the contours of the corresponding
landscape, and adaptation to an environment involves a
mutational walk from one point in the fitness landscape to another
(Figure 2A). In quasispecies theory, a network of mutationally
coupled variants will span the corresponding peaks and valleys of
the fitness landscape. A fast replicating population well suited to a
given environment will inhabit a high and narrow peak in the
fitness landscape, while a less fit but more genetically diverse
population will occupy a lower, broader one.
A viral quasispecies, then, is a cloud of diverse variants that are
genetically linked through mutation, interact cooperatively on a
functional level, and collectively contribute to the characteristics of
the population. The unit of selection is the population as a whole,
and the nature of the functional interactions among genetically
distinct variants is therefore of critical importance to pathogenesis
in infected hosts. These effects and their biomedical implications
are described below.
The Problem of Fitness and Survival of the
Flattest
Mutation and selection are the most fundamental processes in
evolution. In Darwinian evolution, natural selection acts on
existing genetic variation to optimize fitness. Conceptually, fitness
refers to how well a given organism ‘‘fits’’ into its environment,
often reflected in how well it survives and reproduces [19]. In
experimental settings, precise fitness measurements are para-
mount, and virologists typically use replicative capacity as a
surrogate for fitness [20]. While replication is useful as a first
approximation, other factors such as immune escape, transmissi-
bility, and cellular tropism are important components of fitness in
the dynamic host environment [21]. Furthermore, because
quasispecies theory adds the complexity of mutant networks, we
must incorporate a population-based model into our fitness
definition.
Measuring the fitness of individual variants within a population
maymisrepresentthefitnessofa quasispecies.Earlyexperimentswith
vesicular stomatitis virus (VSV) established that high fitness variants
could be suppressed to low levels within a complex population [22].
Conversely, longitudinal studies of dengue virus isolates have
identified defective clones that are stably maintained at a high
frequency in the population [23]. Further consideration of the fitness
landscape model may explain these paradoxical results (Figure 2B).
Consider two populations, generated from either a fast replicator or a
slower one. At low mutation rates, the fast replicator will triumph
because its progeny are genetically identical and generated more
quickly. In the fitness landscape, this population occupies a tall,
narrow peak, where there is little genotypic diversity and maximal
fitness. In RNA viruses, elevated mutation rates mean that a fast
replicator will give rise to genetically diverse progeny, many of which
are significantly less fit than the parent. Quasispecies theory predicts
that slower replicators will be favored if they give rise to progeny that
areonaveragemorefit;thesepopulationsoccupyshort,flatregionsof
the fitness landscape [18]. This effect, termed survival of the flattest,
Figure 1. RNA viruses exist as a quasispecies. A virus replicating with a high mutation rate will generate a diverse mutant repertoire over the
course of a few generations. In these trees, each branch indicates two variants linked by a point mutation and the concentric circles represent serial
replication cycles. The resulting distribution is often represented as a cloud centered on a master sequence. This two dimensional schematic is a vast
oversimplification of the intraquasispecies connectivity. In the mathematical formulations of quasispecies theory, sequence space is
multidimensional, with numerous branches between variants.
doi:10.1371/journal.ppat.1001005.g001
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[24–28]. Flat quasispecies accept mutation without a corresponding
effect on fitness, and these mutationally robust populations form a
large, selectively neutral network of variants in sequence space. While
neutral mutations do not change the corresponding phenotype, they
may have epistatic effects on subsequent mutations and redraw the
genotype–phenotype map [29].
A flat quasispecies with an expansive mutant repertoire can
explore vast regions of sequence space without consequence and
is poised to adapt to rapid environmental change. This
framework may explain many observed phenomena with direct
clinical relevance. Arboviruses must successfully adapt to insect
and mammalian hosts and their associated fitness landscapes. A
quasispecies that occupies a broad, flat region of sequence space
Figure 2. The fitness landscape and survival of the flattest. (A) Population 1 has high fitness but is trapped in sequence space because
mutation leads to a dramatic loss of fitness. Population 2 is more mutationally robust because mutation leads to minor fitness losses. The flatter
population is ideally situated to move through sequence and access other local peaks through neighboring mutational networks (indicated in
different colors). (B) At low mutation rates, variants will be genotypically stable and cluster at the top of the fitness peak. The variant with the highest
fitness will easily outcompete all others. At high mutation rates, variants spread out over the corresponding peaks. Variants on the flatter peak (green)
remain near their fitness optimum and have a higher mean fitness than the population located on the steeper peak (red). The flatter population will
prevail.
doi:10.1371/journal.ppat.1001005.g002
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environment. Similarly, retrospective studies of primary HIV
isolates suggest that HIV could be moving to a flatter and less fit
region of sequence space [20,30–32]. In the case of influenza,
detailed antigenic mapping of the hemagglutinin protein
suggests that interpandemic strains remain antigenically stable
for years despite genetic drift and evolve over a neutral region of
sequence space. This steady accumulation of genetic diversity is
punctuated by epochal shifts in antigenicity [33]. Though this
adaptive process occurs on the interhost level over a long time
scale, it highlights the importance of ‘‘flatness’’ in viral
evolution.
Error Catastrophe
Given their high mutation rates, it is not surprising that many
discussions of RNA virus evolution focus on the relationship
between genetic diversity and adaptability. While it is clear that
RNA viruses have the capacity to quickly explore large regions of
sequence space, genome size and selective constraints place
significant limitations on the amount of diversity that is actually
expressed [34]. Most RNA virus genomes are relatively small and
contain either overlapping reading frames or sequences that serve
both coding and structural functions. Similarly, coding mutations
that mediate escape from host immune surveillance may
compromise protein function. In VSV, for example, approximate-
ly 60% of spontaneous mutations are deleterious [35]. Evolution-
ary theory would suggest that the short-term cost of mutation is
balanced by the long-term benefit of adaptability in the face of a
dynamic environment [36,37].
Quasispecies theory accepts this trade-off, and proposes an
upper limit to mutation rate, the ‘‘error threshold’’ (Figure 3A).
According to Eigen’s original formulations, a quasispecies can
remain at equilibrium despite a high mutation rate [38,39]. Small
increases in mutation rate will upset this balance as the master
sequence itself disappears and meaningful genetic information is
lost in an avalanche of errors. Because Eigen compared this
process to chemical phase transitions, it has been termed
‘‘mutational meltdown.’’ It is now clear that many RNA viruses
replicate near the error threshold. Early studies with VSV showed
that chemical mutagens generally reduced viral infectivity, and
studies with poliovirus clearly demonstrated that mutagenic
nucleoside analogs push viral populations to extinction [40–43].
The effect is dramatic—a 4-fold increase in mutation rate resulted
in a 95% reduction in viral titer. Others have found similar results
with lymphocytic choriomeningitis virus (LCMV) and foot and
mouth disease virus (FMDV) [44–48]. The lethal mutagenesis of
viral populations is perhaps the most important implication of the
error threshold.
Recent work on host cell restriction of retroviral infection
suggests that lethal mutagenesis is a natural form of antiviral
defense [49]. The cytidine deaminase APOBEC3G was initially
identified as a protein targeted by the HIV Vif protein during
replication [50]. Humans have 11 APOBEC proteins that edit
cellular messages by converting cytosine bases to uracil. Subse-
quent work demonstrated that APOBEC proteins could induce
lethal mutagenesis of HIV through widespread deamination of the
HIV genome during reverse transcription, and highly mutagen-
ized HIV genomes with signatures of deamination have been
observed in patients [51–56]. This mechanism appears to be
evolutionarily conserved and active against hepatitis B virus,
simple retroviruses, and endogenous retroelements [57]. While
mutation-independent activities have also been identified, it is
clear that APOBEC-mediated lethal mutagenesis is a critical
cellular defense against RNA viruses. The fact that these
pathogens replicate close to the error threshold makes them
particularly sensitive to slight increases in mutational load
(Figure 3A).
These observations suggest that lethal mutagenesis could be an
effective therapeutic strategy for RNA virus infections [58].
Ribavirin, a nucleoside with broad antiviral activity, has attracted
considerable interest, and can induce lethal mutagenesis of
Hantaan virus and poliovirus [42,43,59]. While ribavirin is used
clinically for the treatment of both respiratory syncytial virus and
hepatitis C virus, it has pleiotropic effects, and its mechanism of
action in these infections is unclear [60]. Another mutagen, 5-
fluorouracil, is licensed as a chemotherapeutic agent, and its
antiviral activity against LCMV in animal models may predict
efficacy for other arenaviruses, such as Lassa fever [61,62].
Spurred by these results, Loeb and colleagues have identified a
number of nucleoside analogs capable of inducing the lethal
mutagenesis of HIV [63–65].
While these results are encouraging, much work needs to be
done before lethal mutagenesis can be considered as a
quasispecies-inspired therapeutic strategy. Some have argued
for a distinction between lethal mutagenesis and error
catastrophe, and have suggested, on theoretical grounds, that
the above experiments do not show a true phase transition with
loss of a master sequence. Indeed, careful studies of lethal
mutagenesis by Lowenstein and colleagues have shown an
imperfect correlation between mutational load and population
extinction [46]. Pre-extinction populations exhibit marked
heterogeneity in both the location and number of mutations
per genome. The dynamics of extinction are further complicat-
ed by the observation that highly mutagenized genomes can
accelerate extinction by interfering with the replication of their
less mutated brethren [47,66]. In that case, a mutagenized
population would collapse without the genetic melting of an
error catastrophe. While these discrepancies may reflect the gap
between mathematical theory and biological complexity, the
distinction could have ‘‘real world’’ implications. Mutation is a
double-edged sword, and adaptive evolution can be accelerated
at high mutation rates [67]. Absent a true mutational meltdown,
a large pre-extinction population could serve as a reservoir for
novel mutants that mediate antiviral resistance or immune
escape [68–70].
The potential for mutagen resistance is another important
concern. In principle, a virus could evolve biochemical resistance
to nucleosides either by excluding the drug from its active site or
by lowering its intrinsic error rate (see below). Quasispecies theory
suggests that viruses could also achieve resistance by moving to
flatter regions of the fitness landscape, where the density of neutral
mutations is higher. Combination therapy with mutagens and
traditional antivirals may minimize the probability of mutagenic
escape, and work in the FMDV system is encouraging [71,72].
The safety of nucleoside analogs is a major concern that is largely
unexplored. Drug concentrations in the above studies were often
in the millimolar range, and mutagenic nucleosides with a wider
therapeutic index are clearly needed. Given the potential for off-
target effects on host cell polymerases, therapy would likely need to
be short term—a problem for HIV, where eradication of the latent
reservoir is critical.
Mutation Rate, Virulence, and Attenuation
Evolutionary theory predicts that high mutation rates are
favored in a dynamic environment, and viral error rates may have
been optimized by natural selection [36,37]. For RNA viruses, low
PLoS Pathogens | www.plospathogens.org 4 July 2010 | Volume 6 | Issue 7 | e1001005replicative fidelity generates a diverse population of variants.
While these variants are generally less fit, they may quickly
dominate if a sudden change in environment, such as immune
pressure, shifts the corresponding fitness landscape. Conversely, a
homogeneous population, generated by high replicative fidelity,
would lack this flexibility and might be less successful in the
dynamic host environment.
Recent work by two groups in the poliovirus system provides
experimental support for this model. Drawing on experience with
ribavirin and lethal mutagenesis, they hypothesized that a mutant
with a low mutation rate would be less sensitive to lethal
mutagenesis and resistant to ribavirin. Both groups sought to
isolate ribavirin resistant mutants from a poliovirus quasispecies
and recovered a variant with a single amino acid substitution in
Figure 3. Mutant distributions and the error threshold. (A) The majority of viruses in a wild-type population has few mutations and is
viable Some viruses, bearing a higher mutational load, are nonviable and considered beyond the threshold of error catastrophe (shown in
green). Small increases in mutation frequency, mediated by host APOBEC proteins or exogenous mutagen, push the distribution to the right,
past the error threshold. The number of errors per genome is sufficiently high to lethally mutate a majority of the population. (B) A high fidelity
polymerase results results in a narrower quasispecies situated farther from the error threshold. This population is more resistant to the effect of
mutagen, because it does not accumulate as many mutations, as the wild type does not cross the error threshold. Figure adapted from Crotty
et al. [42].
doi:10.1371/journal.ppat.1001005.g003
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G64S) [73,74]. This mutant was
relatively resistant to lethal mutagenesis, and assays for selectable
markers indicated that the G64S population had a lower
mutation rate and exhibited less genetic diversity (Figure 3B)
[73,75,76]. While wild-type and G64S quasispecies replicated
with similar kinetics, the former was more ‘‘fit’’ in direct
competition assays [75,76]. Together, these data suggested that
high mutation rates confer an evolutionary advantage to RNA
viruses.
The G64S quasispecies was markedly attenuated in a transgenic
mouse model for poliovirus infection; the high fidelity variants
were less successful at accessing the central nervous system (CNS),
the site of disease [76]. Importantly, virulence was determined in
large part by the diversity of the coinfecting population (Figure 4).
When brain-derived polioviruses were introduced as members of
the genetically homogeneous G64S population, they were not able
to invade the CNS. In contrast, brain-derived viruses readily
accessed the CNS when the population inoculum contained a
wild-type distribution of variants. These results suggest that
quasispecies diversity, rather than the selection of individual
variants, correlates with enhanced virulence [76]. The demon-
stration of cooperative interactions among mutants in a population
established the relevance of quasispecies theory to studies of viral
pathogenesis. Vignuzzi and colleagues extended this model and
hypothesized that the observed attenuation of the high fidelity
variants could be exploited for vaccine design [77]. Focusing on
the G64 position, they engineered several high fidelity mutants
that were markedly attenuated in mice. These viruses stimulated
high titers of neutralizing antibody in immunized mice, and
provided lasting protection against subsequent lethal challenge
with wild-type virus.
This work shows how quasispecies theory and its predictions can
lead to the rational development of live, attenuated vaccines.
Because variants with low mutation rates would be less likely to
revert to wild type in a vaccinee, attenuation should be a stable
phenotype and increase the safety of candidate vaccines. Caution
is warranted, however, since the error rates of the high fidelity
variants are still orders of magnitude greater than those of DNA
viruses. It is also unclear whether reducing mutation rate will
similarly affect the adaptability and virulence of other RNA
viruses. Further work in other systems is clearly needed before this
work can be translated into new vaccines [78,79]. As in the case of
lethal mutagenesis, the modulation of fidelity offers an opportunity
to use mutation rate as a therapeutic strategy for the control of
viral disease.
Perspectives on the Future
Quasispecies theory has had a profound influence on
virology, and experiments with model RNA viruses have
validated many of its predictions. Considerably less is known
about how its population-based models apply to the evolution-
ary behavior of RNA viruses in infected hosts, and it will be
challenging to translate them to the complex reality of viral
infection in patients. The initial studies pose as many questions
as they answer. What is the best measure of viral fitness in a
dynamic population? How can we use a fitness landscape model
to understand selection pressure in vivo, where many such
landscapes coexist? Do the principles of mutational robustness
and survival of the flattest determine the behavior of
populations in the host ecosystem? How does population
diversity influence pathogenesis? What are the mechanisms by
which variants or subpopulations cooperate, and does this have
implications for coinfection?
While early forays into complex experimental systems have
provided tantalizing results, much more work is needed in this
area if quasispecies theory is to be translated from bench to
bedside. Improved assays for characterizing viral populations are
critical, and the advent of ultra high throughput, or ‘‘deep’’
sequencing, is particularly exciting. Several groups have used this
technology to explore the complexity of mutant spectra in clinical
samples from HIV- and HBV-infected patients, although the
sequencing error rate presents certain limitations for studies of
RNA as opposed to DNA viruses [80–82]. Discerning quasispecies
structure from the wealth of sequencing data presents significant
computational challenges as well, since current techniques are
underdeveloped and do not permit us to determine which
mutations are linked on the same genome. Complementary
approaches, such as molecular barcoding, will also be required if
we are to understand how the mutant spectrum changes
temporally or spatially within an infected host [83]. Finally, future
drug and vaccine studies will need to be carried out in well-defined
animal models, as subtle differences can have a significant impact
on experimental outcome. Despite these obstacles, we are
confident that quasispecies theory will soon move out of the
Figure 4. Population diversity is a virulence determinant. Results of experiments described in Vignuzzi et al. [76]. A neurovirulent clone of
poliovirus was isolated from the brains of mice that had been infected with a wild-type strain. Naive mice were then reinfected with this clone as part
of either a genetically constrained (top) or diverse population (bottom). Although all mice received the neurovirulent clone, only those infected with
a diverse quasispecies developed disease. Subpopulations within the diverse quasispecies cooperated with the neurovirulent clone to facilitate its
entry into the CNS.
doi:10.1371/journal.ppat.1001005.g004
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viral disease.
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